Viewing StudyNCT06440135

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-06-16 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06440135
Status: RECRUITING
Last Update Posted: 2024-06-03
First Post: 2024-03-05
Brief Title: Ziftomenib Maintenance Post Allo-HCT
Sponsor: Massachusetts General Hospital
Organization: Massachusetts General Hospital
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
KMT2A Rearrangement
Acute Myeloid Leukemia
Acute Myeloid Leukemia in Remission
NPM1 Mutation
Keywords:
Name View
KMT2A Rearrangement View
Acute Myeloid Leukemia View
Allogeneic hematopoietic cell transplantation HCT View
Allo-HCT View
NPM1 Mutation View